Publication illustrates foundational innovation that has defined the company’s advanced platform integrating high-dimensional transcriptomics and AI predictive modeling for drug discovery Cellarity, a ...

In the rapidly evolving field of drug discovery, single-cell analysis has become an invaluable tool for understanding cellular heterogeneity and molecular pathways. However, traditional single-cell ...

Single B-cell technologies have emerged as powerful screening tools to accelerate antibody discovery, offering R&D teams the potential to interrogate millions of individual antibody-secreting cells to ...

SOMERVILLE, Mass., October 23, 2025 – Cellarity, a biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the publication of a ...